Zhejiang Jolly Pharmaceutical Co Ltd Class A

Zhejiang Jolly Pharmaceutical Co Ltd Class AChina

€2.13
Dividend Yield (FWD)
2.72%
Annual Payout (FWD)
CN¥0.45
Dividend Growth Rate (CAGR)
#.##%
Ex-DatePay DateAmountChange
CN¥0.45
50%
CN¥0.45
50%
CN¥0.30
50%
CN¥0.30
50%
CSV Export

Zhejiang Jolly Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 2.72%.

ISIN
WKN
-
Symbol / Exchange
/ XSHE
Value
€2.13
Dividend frequency
annually
Security Type
Equity
Sector

Health Care

Country
China

China

Dividend Currency
Chinese Yuan
Resources

Frequently Asked Questions about Zhejiang Jolly Pharmaceutical Co Ltd Class A

Within the last 12 months, Zhejiang Jolly Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.45. For the next 12 months, Zhejiang Jolly Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.45. This corresponds to a dividend yield of approximately 2.72%.
The dividend yield of Zhejiang Jolly Pharmaceutical Co Ltd Class A is currently 2.72%.
Zhejiang Jolly Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in May.
The next dividend for Zhejiang Jolly Pharmaceutical Co Ltd Class A is expected in May.
Zhejiang Jolly Pharmaceutical Co Ltd Class A paid dividend every year within the last 10 years.
Dividends of CN¥0.45 are expected for the next 12 months. This corresponds to a dividend yield of 2.72%.
Zhejiang Jolly Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
The last stock split of Zhejiang Jolly Pharmaceutical Co Ltd Class A was on 20 May 2015 in the ratio 17:10.
To receive the last dividend of Zhejiang Jolly Pharmaceutical Co Ltd Class A on 22 May 2024 in the amount of CN¥0.45 you had to have the stock in your portfolio before the ex-day on 22 May 2024.
The last dividend was paid on 22 May 2024.
In 2022, dividends of CN¥0.20 were paid by Zhejiang Jolly Pharmaceutical Co Ltd Class A.
Dividends from Zhejiang Jolly Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
The headquarters of Zhejiang Jolly Pharmaceutical Co Ltd Class A is located in China.